Back Back to portfolio

Inoviv

Inoviv uses a novel technology platform based on targeted proteomics to support pharmaceutical companies with biomarker test development.

inoviv.com

Founded In

2017

Fund

Hoxton III

Headquarters

London, UK

Invested In

2021

Hoxton Partners

Rob Kniaz